EUROAPI

The global halal empty capsules market is projected to grow from USD 1.28 billion in 2024 to USD 2.16 billion by 2034, driven by increasing demand for halal-certified products and plant-based capsules. North America dominated the market in 2023, while Asia Pacific is expected to grow fastest. The gelatin segment led in 2023, but non-gelatin is projected to grow significantly. The pharmaceutical industry is the largest application segment, with the nutraceutical segment expected to grow rapidly. AI is enhancing drug manufacturing processes, and rising demand for dietary supplements and generic drugs is boosting market growth. Challenges include the lack of halal-certified raw materials and the costly certification process.

The oligonucleotide CDMO market is projected to grow from USD 2.51 billion in 2024 to USD 6.73 billion by 2029, with a CAGR of 21.8%. Key players include Thermo Fisher Scientific, Lonza, and Agilent Technologies. The market's expansion is driven by increasing demand for therapeutic, research, and diagnostic applications across pharma and biotech sectors.